Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Nov 21, 2022
Date Accepted: Feb 28, 2023
Date Submitted to PubMed: Mar 6, 2023

The final, peer-reviewed published version of this preprint can be found here:

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

Argyropoulos CD, Leckler J, Salmanton-García J, Constantinou M, Alexandrou A, Themistocleous S, Noula E, Shiamakkides G, Nearchou A, Stewart FA, Albus K, Koniordou M, Kopsidas I, Spivak O, Hellemans M, Hendrickx G, Davis RJ, Azzini AM, Valle-Simón P, Carcas AJ, Askling HH, Vene S, Prellezo JB, Álvarez-Barco E, Macken A, Di Marzo R, Luís C, Olesen OF, Frias-Iniesta J, Barta I, Toth K, Akova M, Bonten MM, Cohen-Kandli M, Cox RJ, Součková L, Husa P, Jancoriene L, Launay O, Lundgren J, Mallon P, Mendonça MA, Marques L, Nauclér P, Ochando J, Tacconelli E, van Damme P, Zaoutis TE, Hofstraat SHI, Bruijning P, Zeitlinger M, Cornely OA, Pana ZD

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

JMIR Public Health Surveill 2023;9:e44491

DOI: 10.2196/44491

PMID: 36878478

PMCID: 10131613

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Per the author's request this version is not available.